Gonorrhea Testing: Window Periods, Accuracy, and What National Data Show

Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It can infect the genitals, rectum, and throat, and is spread through vaginal, anal, or oral sex. People of any gender can get gonorrhea, and it is the second most commonly reported nationally notifiable STI in the United States behind chlamydia.

One characteristic shapes everything else about it: gonorrhea can establish infection at several sites, and infection at the throat or rectum in particular is often quiet. That makes site-appropriate testing — not just a urine sample — part of an accurate picture for anyone with oral or anal exposure.

CDC states plainly that gonococcal infections can be asymptomatic. When symptoms occur, they may include discharge, burning during urination, or irritation — and rectal infection can cause discharge, itching, or soreness, while throat infection frequently causes nothing noticeable at all. Symptoms can also fade while infection persists.

Surveillance data reflect this: CDC notes that reported case trends are influenced both by changes in new infections and by how much screening happens. Many gonorrhea cases are found through screening rather than symptom-driven visits, which is why testing on schedule matters even when nothing feels wrong.

Gonorrhea is most commonly detected with a nucleic acid amplification test (NAAT) on urine or swab specimens. CDC treatment guidance describes NAAT sensitivity for gonorrhea as superior to culture at urogenital and other sites, and FDA-cleared NAATs cover urine, vaginal swabs, and rectal and pharyngeal swabs — the tools needed to test every site of exposure.

Timing still governs the result: a test taken too early can miss a recent infection regardless of the method's quality. CDC does not publish a single fixed window number for gonorrhea NAATs; in practice, testing about 1 to 2 weeks after a possible exposure is a commonly used interval, and CDC post-exposure guidance supports repeating an earlier negative NAAT at that point when a recent exposure is possible. If you tested only days after an exposure, treat that negative as provisional and plan a follow-up.

Because the pharynx and rectum are common hidden sites — and because pharyngeal infection in particular can be harder to detect with some assays — a full picture after oral or anal sex may involve swabs in addition to urine. A clinician or the testing service you use can indicate which sites your ordered test covers.

CDC documents that untreated gonococcal infection can spread beyond the genitals, causing disseminated gonorrhea infections that affect joints, skin, and other organs, and that untreated infection in women can contribute to pelvic inflammatory disease. Gonorrhea also raises the risk of acquiring and transmitting HIV, and strains resistant to antibiotics are a growing public health concern — another reason infections are identified early rather than left to chance.

A positive result connects you to the next step with a healthcare provider; a negative result, correctly timed, lets you stop guessing. Either way the test answers a question that symptoms alone cannot.

CDC's 2023 surveillance report counted 601,319 reported gonorrhea cases in the United States — a national rate of 179.5 per 100,000, down 7.7 percent from 2022 and the second consecutive year of decline after the post-2009 climb. CDC cautions that declines in reported gonorrhea may reflect fewer new infections, reduced screening, or both.

Local burdens differ. Across the 100 largest US metros, 2023 metro-level surveillance data show a mean gonorrhea rate of 257.61 per 100,000 with a standard deviation of 94.26, so metro-to-metro variation is substantial. The national direction is a genuine bright spot in recent STI data — CDC headline framing notes the broader STI epidemic may be slowing — while the practical advice for individuals is unchanged: test on a schedule that matches your risk.

Lab-based gonorrhea testing through an online order is processed at a Labcorp or Quest patient service center, with thousands of locations nationwide. A single gonorrhea test can be ordered on its own, or as part of a broader STD panel — a common choice when chlamydia, syphilis, or other infections are also a realistic possibility, since co-infection with chlamydia is frequent enough that CDC recommends testing for it whenever gonorrhea is found.

Insurance is not required. Claims processed through insurance can appear on an explanation of benefits; self-pay keeps the lab visit off insurance records, which is why many people pay out of pocket. See the STDcheck pricing page for current single-test and panel pricing, and note that a $10-off coupon flow is available at checkout.